BE905067A - Androsta-1,4-diene-3,17-diones substituees, leur procede de fabrication et medicaments les contenant. - Google Patents

Androsta-1,4-diene-3,17-diones substituees, leur procede de fabrication et medicaments les contenant.

Info

Publication number
BE905067A
BE905067A BE0/216890A BE216890A BE905067A BE 905067 A BE905067 A BE 905067A BE 0/216890 A BE0/216890 A BE 0/216890A BE 216890 A BE216890 A BE 216890A BE 905067 A BE905067 A BE 905067A
Authority
BE
Belgium
Prior art keywords
androsta
diene
manufacturing process
medicines containing
treatment
Prior art date
Application number
BE0/216890A
Other languages
English (en)
French (fr)
Inventor
Buzzetti Franco
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10582036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE905067(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE905067A publication Critical patent/BE905067A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/216890A 1985-07-09 1986-07-08 Androsta-1,4-diene-3,17-diones substituees, leur procede de fabrication et medicaments les contenant. BE905067A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858517360A GB8517360D0 (en) 1985-07-09 1985-07-09 Substituted androsta-1,4-diene-3,17-diones

Publications (1)

Publication Number Publication Date
BE905067A true BE905067A (fr) 1987-01-08

Family

ID=10582036

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216890A BE905067A (fr) 1985-07-09 1986-07-08 Androsta-1,4-diene-3,17-diones substituees, leur procede de fabrication et medicaments les contenant.

Country Status (38)

Country Link
US (2) US4808616A (cg-RX-API-DMAC7.html)
JP (1) JPS6212797A (cg-RX-API-DMAC7.html)
KR (1) KR950003614B1 (cg-RX-API-DMAC7.html)
CN (1) CN86104664B (cg-RX-API-DMAC7.html)
AT (1) AT395157B (cg-RX-API-DMAC7.html)
AU (1) AU578840B2 (cg-RX-API-DMAC7.html)
BE (1) BE905067A (cg-RX-API-DMAC7.html)
BG (1) BG61370B2 (cg-RX-API-DMAC7.html)
BR (1) BR1100240A (cg-RX-API-DMAC7.html)
CA (1) CA1277656C (cg-RX-API-DMAC7.html)
CH (1) CH668599A5 (cg-RX-API-DMAC7.html)
CS (2) CS257794B2 (cg-RX-API-DMAC7.html)
CZ (1) CZ413591A3 (cg-RX-API-DMAC7.html)
DE (1) DE10199030I1 (cg-RX-API-DMAC7.html)
DK (1) DK163520C (cg-RX-API-DMAC7.html)
ES (2) ES8801304A1 (cg-RX-API-DMAC7.html)
FI (1) FI83424C (cg-RX-API-DMAC7.html)
FR (1) FR2584725B1 (cg-RX-API-DMAC7.html)
GB (2) GB8517360D0 (cg-RX-API-DMAC7.html)
GR (1) GR861780B (cg-RX-API-DMAC7.html)
HK (1) HK94190A (cg-RX-API-DMAC7.html)
HU (1) HU194274B (cg-RX-API-DMAC7.html)
IE (1) IE58949B1 (cg-RX-API-DMAC7.html)
IL (1) IL79336A (cg-RX-API-DMAC7.html)
IT (1) IT1196436B (cg-RX-API-DMAC7.html)
MY (1) MY102294A (cg-RX-API-DMAC7.html)
NL (2) NL193616C (cg-RX-API-DMAC7.html)
NO (2) NO165547C (cg-RX-API-DMAC7.html)
NZ (1) NZ216763A (cg-RX-API-DMAC7.html)
PH (1) PH21785A (cg-RX-API-DMAC7.html)
PT (1) PT82944B (cg-RX-API-DMAC7.html)
SE (1) SE468988B (cg-RX-API-DMAC7.html)
SG (1) SG80490G (cg-RX-API-DMAC7.html)
SK (1) SK413591A3 (cg-RX-API-DMAC7.html)
SU (2) SU1442077A3 (cg-RX-API-DMAC7.html)
UA (1) UA6046A1 (cg-RX-API-DMAC7.html)
YU (2) YU44585B (cg-RX-API-DMAC7.html)
ZA (1) ZA865079B (cg-RX-API-DMAC7.html)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
DE3715869A1 (de) * 1987-05-07 1988-11-17 Schering Ag Verfahren zur herstellung von 1-methyl-androsta-1,4-dien-3,17-dion und die neuen zwischenprodukte fuer dieses verfahren
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
GB8721383D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia Preparation of methylene derivatives
GB8801697D0 (en) * 1988-01-26 1988-02-24 Erba Farmitalia Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione
ATE154032T1 (de) * 1991-03-28 1997-06-15 Teikoku Hormone Mfg Co Ltd Neue d-homo-17-oxa und d-homo-17-aza- androstanderivate
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9201224D0 (en) * 1992-01-21 1992-03-11 Erba Carlo Spa Difluoromethylenandrostenone derivatives and process for their preparation
AU665455B2 (en) * 1992-09-30 1996-01-04 Teikoku Hormone Mfg. Co., Ltd. Novel 7-substituted oxa- or azasteroid compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9313420D0 (en) * 1993-06-29 1993-08-11 Erba Carlo Spa Fluorinated 6-methylenandrosta-1,4-dien-3-one-derivatives and process for their preparations
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
WO2001004342A1 (en) * 1999-07-07 2001-01-18 Pharmacia & Upjohn Company Process to prepare exemestane
GB9930839D0 (en) * 1999-12-30 2000-02-16 Pharmacia & Upjohn Spa Process for treating gynecomastia
GB0005257D0 (en) * 2000-03-03 2000-04-26 Pharmacia & Upjohn Spa Breast cancer hormonal therapy
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0017635D0 (en) * 2000-07-18 2000-09-06 Pharmacia & Upjohn Spa Antitumor combined therapy
EP1322333A2 (en) * 2000-08-09 2003-07-02 Pharmacia Italia S.p.A. Composition for combined use of aromatase inhibitors
AU8986501A (en) * 2000-09-08 2002-03-22 Pharmacia & Upjohn Spa Exemestane as chemopreventing agent
US20040082557A1 (en) * 2001-01-26 2004-04-29 Wajszczuk Charles Paul Methods for treating estrogen-dependent disorders
JP2004519490A (ja) * 2001-01-26 2004-07-02 フアルマシア・イタリア・エツセ・ピー・アー エキセメスタンによるホルモン依存性異常症の組合せ治療方法
PL231418B1 (pl) 2001-02-19 2019-02-28 Novartis Ag 40-O-( 2-hydroksyetylo)- rapamycyna do zastosowania w leczeniu guzów litych płuc, innych niż nowotwór tkanki limfatycznej
KR20080091866A (ko) 2001-05-16 2008-10-14 노파르티스 아게 Ν-｛5-[4-(4-메틸-피페라지노-메틸)-벤조일아미도]-2-메틸페닐｝-4-(3-피리딜)-2-피리미딘-아민 및 화학치료제를 포함하는 배합물
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
US20040043938A1 (en) * 2001-11-06 2004-03-04 Dinesh Purandare Combination therapy for estrogen-dependent disorders
GB0128510D0 (en) * 2001-11-28 2002-01-23 Novartis Ag Organic compounds
PL372103A1 (en) 2002-05-16 2005-07-11 Novartis Ag Use of edg receptor binding agents in cancer
CN1317293C (zh) * 2002-10-24 2007-05-23 南京长澳医药科技有限公司 一种依西美坦的合成工艺
CN1304413C (zh) * 2002-10-24 2007-03-14 上海华拓医药科技发展有限公司 一种抗癌药物依西美坦制备方法
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
WO2005027916A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
US20050101579A1 (en) * 2003-11-06 2005-05-12 Shippen Eugene R. Endometriosis treatment protocol
EP1709062B9 (en) 2004-01-16 2013-02-13 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
US20080119447A1 (en) * 2005-09-30 2008-05-22 James Yarger 6-alkoxyalkyl estradiol derivatives and methods of use
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
EP1931385B1 (en) 2005-09-30 2018-02-28 Endece, LLC (s)-6-methyloxaalkyl exemestane compounds and related methods of use
DE102006008074B4 (de) * 2006-02-22 2013-08-14 RUHR-UNIVERSITäT BOCHUM Behandlung von Krebs mit Geruchsrezeptor-Liganden
CN101443002B (zh) 2006-05-09 2012-03-21 诺瓦提斯公司 包含铁螯合剂和抗肿瘤药的组合及其用途
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors
EA017385B1 (ru) 2007-10-16 2012-12-28 Репрос Терапьютикс Инк. Применение транс-кломифена для снижения концентрации глюкозы в сыворотке
EP2070943A1 (en) * 2007-12-14 2009-06-17 Crystal Pharma, S.A. Process for obtaining 6-Alkylidenandrost-1,4-diene-3one
CN101468023B (zh) * 2007-12-26 2011-02-02 上海复星医药（集团）股份有限公司 依西美坦片及其制备工艺
US8288571B2 (en) * 2008-01-21 2012-10-16 Cadila Healthcare Limited Process for preparing aromatiase inhibitor exemestane
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
WO2010076811A2 (en) * 2008-12-30 2010-07-08 Ind-Swift Laboratories Limited Process for the preparation of exemestane
WO2010127297A1 (en) 2009-05-01 2010-11-04 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
RU2425052C1 (ru) * 2010-03-04 2011-07-27 Татьяна Степановна Савинова Способ получения 6-метиленандрост-4-ен-3,17-диона из андрост-4-ен-3,17-диона, способ получения 6-метиленандроста-1,4-диен-3,17-диона (эксеместана) с использованием полученного 6-метиленандрост-4-ен-3,17-диона
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
EP2556082B1 (en) 2010-04-08 2017-02-22 Emory University Substituted androst-4-ene diones
JP2013525296A (ja) 2010-04-16 2013-06-20 ノバルティス アーゲー 内分泌療法抵抗性乳癌の処置
BR112013005843A2 (pt) 2010-09-14 2019-12-10 Endece Llc derivativos de er-beta 6-substituído por desmetil-estradiol
AU2013225869B2 (en) 2012-02-29 2017-06-08 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
US20170165246A1 (en) * 2014-02-11 2017-06-15 Novartis Ag Pharmaceutical combinations comprising a pi3k inhibitor for the treatment of cancer
US11633382B2 (en) 2015-11-10 2023-04-25 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (cg-RX-API-DMAC7.html) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
US3112305A (en) * 1960-11-07 1963-11-26 British Drug Houses Ltd 6-methylene-3-oxo-delta4-steroids and process for their preparation
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
BE759143A (fr) * 1969-11-19 1971-05-19 Upjohn Co Procede de preparation d'un nouveau compose steroide
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3004508C2 (de) * 1980-02-05 1981-12-10 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur Herstellung von 6-Methylensteroiden
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones

Also Published As

Publication number Publication date
BG61370B2 (bg) 1997-06-30
JPH0443919B2 (cg-RX-API-DMAC7.html) 1992-07-20
FR2584725B1 (fr) 1988-05-13
MY102294A (en) 1992-05-15
IE861821L (en) 1987-01-09
DK324386A (da) 1987-01-10
AU578840B2 (en) 1988-11-03
FI862871A7 (fi) 1987-01-10
FR2584725A1 (fr) 1987-01-16
AT395157B (de) 1992-10-12
GR861780B (en) 1986-11-11
PT82944A (en) 1986-08-01
KR950003614B1 (ko) 1995-04-17
ES8801304A1 (es) 1987-12-16
SK413591A3 (en) 1995-07-11
BR1100240A (pt) 1999-12-28
ATA181986A (de) 1992-02-15
GB2177700A (en) 1987-01-28
ES556550A0 (es) 1987-12-16
CN86104664A (zh) 1987-02-18
YU44628B (en) 1990-10-31
ZA865079B (en) 1987-03-25
CS258498B2 (en) 1988-08-16
GB2177700B (en) 1988-12-07
UA6046A1 (uk) 1994-12-29
NO165547B (no) 1990-11-19
FI83424C (fi) 1991-07-10
NO165547C (no) 1991-02-27
CH668599A5 (de) 1989-01-13
US4808616A (en) 1989-02-28
NL193616B (nl) 1999-12-01
KR870001140A (ko) 1987-03-11
HUT42780A (en) 1987-08-28
FI862871A0 (fi) 1986-07-07
NL300017I1 (nl) 2000-11-01
IL79336A (en) 1991-06-10
PH21785A (en) 1988-02-24
YU44585B (en) 1990-10-31
AU5979986A (en) 1987-01-15
US4904650A (en) 1990-02-27
SU1501923A3 (ru) 1989-08-15
DK324386D0 (da) 1986-07-08
YU103687A (en) 1988-08-31
HK94190A (en) 1990-11-23
GB8616585D0 (en) 1986-08-13
GB8517360D0 (en) 1985-08-14
DK163520B (da) 1992-03-09
DE10199030I1 (de) 2001-10-04
NO2000009I1 (no) 2000-10-05
IE58949B1 (en) 1993-12-01
DK163520C (da) 1992-07-27
SU1442077A3 (ru) 1988-11-30
CS257794B2 (en) 1988-06-15
NL300017I2 (nl) 2001-01-02
NO862753L (no) 1987-01-12
HU194274B (en) 1988-01-28
SE8603046L (sv) 1987-01-10
CZ413591A3 (en) 1994-03-16
NL193616C (nl) 2000-04-04
NL8601785A (nl) 1987-02-02
IT1196436B (it) 1988-11-16
JPS6212797A (ja) 1987-01-21
ES557466A0 (es) 1988-06-01
YU120186A (en) 1988-02-29
IT8621004A0 (it) 1986-07-02
CS521486A2 (en) 1987-09-17
FI83424B (fi) 1991-03-28
CA1277656C (en) 1990-12-11
SE468988B (sv) 1993-04-26
SE8603046D0 (sv) 1986-07-08
NO862753D0 (no) 1986-07-08
CN86104664B (zh) 1988-06-29
IL79336A0 (en) 1986-10-31
PT82944B (pt) 1989-01-30
NZ216763A (en) 1988-05-30
ES8802429A1 (es) 1988-06-01
SG80490G (en) 1990-11-23

Similar Documents

Publication Publication Date Title
BE905067A (fr) Androsta-1,4-diene-3,17-diones substituees, leur procede de fabrication et medicaments les contenant.
CA2013324A1 (fr) Pteridin-4 (3h)-ones, procedes de preparation et medicaments les contenant
EP0874812A1 (fr) Nouveaux derives de 2,3,5 trimethyl-4-hydroxy anilides, leur preparation et leur application en therapeutique
CZ288043B6 (cs) Estery cordoinu, isocordoinu a příbuzných látek, jejich použití a farmaceutický prostředek
BE904757A (fr) Esters gras bi-ou tri-eniques d'erythromycine a, leur procede de preparation et compositons pharmaceutiques et cosmetiques les contenant.
US3781435A (en) Steroid anaesthetics
US3869451A (en) Anaesthetic steroids of the pregnane and 19-norpregnane series
FUKUSHIMA et al. Absence of 21-dehydroxylation in congenital adrenal hyperplasia
US3560532A (en) 3-silyl-ether steroids
FR2407941A1 (fr) Nouveaux derives de cholesterol
FR2366311A1 (fr) Procede pour la preparation de steroides polyhalogenes utiles comme medicaments
BE903376A (fr) Derives de la vitamine d et precurseurs de ceux-ci et compositions pharmaceutiques en contenant
FR2367079A1 (fr) Procede de preparation de nouveaux composes steroidiques ayant une fonction oxygene en position 19
FR290F (fr) Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes.
IL83302A (en) 14,17beta-ethano-14 beta-estratrienes and estratetraenes,processes for their production and pharmaceutical preparations containing them
US3882151A (en) Chemical compounds
BE901278A (fr) Derives de 4,5,6,7-tetrahydrothiazolo [5,4-c] pyridine, procedes pour les preparer et medicament les contenant.
EP0253859A1 (en) Nor-cholanic acid derivatives, a process for their preparation, their use and pharmaceutical compositions containing them.
JPS63280094A (ja) ３−メチレン−４−アンドロステン−１７−オン、その製造法、および該化合物を含有する、エストロゲン生合成阻止作用および受胎能変更作用を有する医薬
BE899114A (fr) Compositions anti-inflamatoires a usage veterinaire et leur procede de preparation
SE332172B (cg-RX-API-DMAC7.html)
FR2399417A1 (fr) Nouveaux derives de la dibenzo (d,g) (1,3,6)dioxazocine, procedes de preparation de ces derives et medicaments contenant ceux-ci
BE902259A (fr) Nouveaux derives d'apovincaminol, procede pour leur preparation et compositions pharmaceutiques les contenant.
HUT34942A (en) Process for the production of new 4-hydroxy -benzhydrols, as well as of therapeutic preparations contaning them
Porter et al. Synthesis, enzyme inhibition, and antitumor activity of new 1, 4-benzoquinone analogs of coenzyme Q10

Legal Events

Date Code Title Description
CCPV Grant of a supplementary protection certificate

Free format text: 2000C/011, EXPIRES: 20110708

RE20 Patent expired

Owner name: *PHARMACIA ITALIA S.P.A.

Effective date: 20060708

CCRE Expiry of a supplementary protection certificate

Owner name: *PHARMACIA ITALIA S.P.A.

Free format text: PRODUCT NAME: EXEMESTANUM; NAT. REGISTRATION NO/DATE: 277 IS 327 F 20000113; FIRST REGISTRATION: GBPL 00032/0236 19981216

Spc suppl protection certif: 2000C/011

Filing date: 20000525

Expiry date: 20060708

Extension date: 20110708

Effective date: 20110708